Chemed CorporationCHENYSE
Loading
CHE Revenue Growth (YoY Quarterly)•-0.10%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-0.10%
-3.2pp
-12.01%
+1.9pp
-10.38%
+2.7pp
-11.61%
+7.3pp
-15.02%
+0.2pp
-9.87%
+1.6pp
-8.97%
+2.2pp
-5.78%
-2.5pp
-6.66%
-3.0pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +9.23% | +9.79% | +3.85% | +3.09% | -0.10% |
| Gross Profit Growth | +2.88% | +6.03% | -10.40% | -13.96% | -12.01% |
| EBITDA Growth | +3.79% | +11.22% | -20.14% | -13.12% | -10.38% |
| Operating Income Growth | +2.23% | +31.00% | -22.74% | -18.89% | -11.61% |
| Net Income Growth | +0.30% | +10.37% | -25.95% | -15.23% | -15.02% |
| EPS Growth | +2.01% | +14.19% | -23.40% | -11.51% | -9.87% |
| EPS Diluted Growth | +2.03% | +14.62% | -23.23% | -11.16% | -8.97% |
| Weighted Average Shares Growth | -1.63% | -3.30% | -3.25% | -3.26% | -5.78% |
| Weighted Average Shares Diluted Growth | -1.82% | -3.75% | -4.23% | -3.63% | -6.66% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +51.91% | -61.27% | +78.81% | -7.88% | -19.03% |
| Free Cash Flow Growth | +57.21% | -73.11% | +84.78% | -14.22% | -22.98% |
| Receivables Growth | -5.70% | +61.21% | -0.04% | +9.72% | +6.67% |
| Inventory Growth | -31.75% | -27.28% | -14.78% | -16.78% | -7.93% |
| Asset Growth | +0.03% | -0.06% | -0.99% | -8.24% | -1.71% |
| Book Value per Share Growth | +2.68% | +3.26% | +2.61% | -9.94% | -7.10% |
| Debt Growth | -9.20% | -0.74% | -0.57% | -4.35% | +9.88% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +3.80% | -8.88% | -0.21% | +3.72% | +1.20% |
1 / 4